Skip to main content

Diametric Capital, LP

SEC CIK
0001719087
Latest filing
Aug 14, 2026

NBIX holding history

Neurocrine Biosciences Inc in every 13F filed by Diametric Capital, LP, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

NBIX overviewAll 13F holders of NBIXFull Q2 2026 holdings

Shares (Q2 2026)
7,486
Value
$1.26M
% of portfolio
0.1%
Quarters held
3
Since Q1 2025
Holdings of NBIX by Diametric Capital, LP, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 20267,486$1.26M0.1%+7,486NewHolders
Q3 20250$00.0%−3,244−100.0%Sold outHolders
Q2 20253,244$407.7K0.2%+81+2.6%AddedHolders
Q1 20253,163$349.8K0.4%+3,163NewHolders